Astria Therapeutics to present at upcoming American College of Allergy, Asthma, and Immunology Annual Scientific Meeting

Astra Therapeutics announced that leading HAE experts will present two posters at the American College of Allergy, Asthma, and Immunology (ACAAI) Annual Scientific Meeting in Boston, Massachusetts on 25 October 2024.

Dr Aleena Banerji MD, Associate Professor of Medicine at Harvard Medical School and Clinical Director of the Allergy and Immunology Unit at Massachusetts General Hospital, will present new quality of life data from initial results from the Phase 1b/2 trial of navenibart (STAR-0215) in a presentation of a poster titled “STAR-0215 Induces Rapid Improvements of Quality of Life in HAE Patients in the ALPHA-STAR Trial.” The presentation will take place in Exhibit Hall A on Friday 25 October at 3:30pm Eastern Standard Time (EST).

Astria sponsored additional quality of life research in people living with HAE that will be presented by Dr Donald Levy MD, Health Sciences Professor of Medicine in the Division of Basic and Clinical Immunology at the University of California at Irvine. Dr Levy will present a poster titled “Quality of Life and Burden of Disease in Patients with Hereditary Angioedema and their Caregivers” in Exhibit Hall A on Friday 25 October at 3:45pm EST.

(Source: Astria)